Combining epigenetic therapy with venetoclax overcomes alemtuzumab resistance in T-cell prolymphocytic leukemia. A case report of a 26-year-old man with a prior history of T-cell acute lymphoblastic leukemia and GI-T lymphoma.
Michael Asger AndersenRebecca ValentinLene Dissing SjöLine BorgwardtKjeld SchmiegelowMette Klarskov AndersenRasmus L MarvigChristina Westmose YdeCarsten Utoft NiemannPublished in: Acta oncologica (Stockholm, Sweden) (2020)